137 related articles for article (PubMed ID: 18511884)
21. Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.
Wang Y; Wei Y; Zhang H; Shi Y; Li Y; Li R
Med Oncol; 2012 Jun; 29(2):1328-34. PubMed ID: 21308489
[TBL] [Abstract][Full Text] [Related]
22. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Ramos AM; Aller P
Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
[TBL] [Abstract][Full Text] [Related]
23. An ROS generator, antimycin A, inhibits the growth of HeLa cells via apoptosis.
Park WH; Han YW; Kim SH; Kim SZ
J Cell Biochem; 2007 Sep; 102(1):98-109. PubMed ID: 17372917
[TBL] [Abstract][Full Text] [Related]
24. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
Park WH
Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
[TBL] [Abstract][Full Text] [Related]
25. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells.
Woo SH; Park IC; Park MJ; Lee HC; Lee SJ; Chun YJ; Lee SH; Hong SI; Rhee CH
Int J Oncol; 2002 Jul; 21(1):57-63. PubMed ID: 12063550
[TBL] [Abstract][Full Text] [Related]
27. The effects of buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on propyl gallate-treated HeLa cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2009 Aug; 24(2):261-8. PubMed ID: 19578799
[TBL] [Abstract][Full Text] [Related]
28. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
Gu S; Chen C; Jiang X; Zhang Z
Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of MG132-induced HeLa cell death by N-acetyl cysteine via reducing reactive oxygen species and preventing glutathione depletion.
Han YH; Yang YM; Kim SZ; Park WH
Anticancer Res; 2010 Jun; 30(6):2107-12. PubMed ID: 20651358
[TBL] [Abstract][Full Text] [Related]
30. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways.
Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ
Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957
[TBL] [Abstract][Full Text] [Related]
32. Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis.
Morales AA; Gutman D; Cejas PJ; Lee KP; Boise LH
J Biol Chem; 2009 May; 284(19):12886-95. PubMed ID: 19279006
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
[TBL] [Abstract][Full Text] [Related]
34. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells.
Golemovic M; Quintás-Cardama A; Manshouri T; Orsolic N; Duzkale H; Johansen M; Freireich EJ; Kantarjian H; Zingaro RA; Verstovsek S
Invest New Drugs; 2010 Aug; 28(4):402-12. PubMed ID: 19468689
[TBL] [Abstract][Full Text] [Related]
35. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
36. Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib.
Huang M; Thomas D; Li MX; Feng W; Chan SM; Majeti R; Mitchell BS
Leukemia; 2013 Oct; 27(10):1970-80. PubMed ID: 23877794
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism.
Bowling BD; Doudican N; Manga P; Orlow SJ
Cancer Chemother Pharmacol; 2008 Dec; 63(1):37-43. PubMed ID: 18297286
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
[TBL] [Abstract][Full Text] [Related]
39. Molecular targets of arsenic trioxide in malignant cells.
Miller WH
Oncologist; 2002; 7 Suppl 1():14-9. PubMed ID: 11961205
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
Liu Q; Hilsenbeck S; Gazitt Y
Blood; 2003 May; 101(10):4078-87. PubMed ID: 12531793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
